News

CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.

DELL, CAT and AMKR led standout gains as Zacks highlighted top-performing portfolios amid volatile markets and inflation worries.

Stock Market Today: The Dow Jones index rose Monday on U.S.-Iran news. SpaceX stock rallied on its addition to the Nasdaq-100 index.

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Stocks That Will Make You Rich Over the Next 3 Years. UnitedHealth Group Incorporated (NYSE:UNH) has gained more than 10% over the past 30 days and is now trading close to its 52-week high. The performance has been driven by positive analyst upgrades and a proposed FTC […]

When it comes to income, investors essentially have two choices: stocks or bonds. While the S&P 500 yields just 1%, there are plenty of pockets of the stock market where investors can snag 3%-plus dividend yields, including utilities, REITs, pipelines, and one of the most hated sectors, cable and telecom. “Yields are very attractive,” says Russ Brownback, BlackRock’s deputy chief investment officer for global fixed income and co-manager of the undefinedBlackRock Strategic Income Opportunities fund.

Is the insurer's recovery already baked into the stock?

In recent days, UnitedHealth Group has drawn attention as analysts highlighted improving operations, a long-running dividend growth record, and a large new AI investment aimed at lowering costs ahead of its mid-July 2026 earnings release. This combination of technology spending, managed care optimism, and consistent capital returns has sharpened the focus on how UnitedHealth’s business model might handle evolving Medicare and cost pressures. With mounting interest in its enterprise-wide AI...

UnitedHealth Group (UNH) reached $427.89 at the closing of the latest trading day, reflecting a +2.97% change compared to its last close.

UnitedHealth's turnaround has caught some investors by surprise.

Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.

UnitedHealth Group (UNH) closed the most recent trading day at $415.53, moving +2.4% from the previous trading session.

With the semiconductor sector showing signs of exhaustion and overvaluation, the AI investment playbook is fundamentally shifting. Investors must now pivot away from hardware builders to traditional firms leveraging AI to slash operational costs and drive margin expansion.

The S&P 500 index was up about 0.3%, while the Nasdaq Composite fell 0.4%.

CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.

UnitedHealth Group Research is set to announce its second-quarter earnings next month, and Wall Street expects the company’s EPS to grow by double digits.

7.50am: 3i reveals slower growth for Action 3i Group said its largest portfolio company, Action, remains on track for a good second quarter despite like-for-like sales growth slowing. Ahead of its annual general meeting on Thursday, the FTSE 100-listed private equity investor said European...

We recently published David Tepper Stock Portfolio: 10 Long-Term Stock Picks. UnitedHealth Group Incorporated (NYSE:UNH) is one of the long-term stock picks. David Tepper’s Appaloosa Management has held a stake in health insurance giant UnitedHealth Group Incorporated (NYSE:UNH)’s shares since the fourth quarter of 2010. It held the shares until the second quarter of 2011. […]

Alphabet's inclusion in the Dow gives the 130-year-old blue-chip index a dose of the same mega-cap tech trade already dominating the Nasdaq 100.

HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.

The "Mad Money" host says, "Buy it." Should you listen?

UnitedHealth’s 24.5% return over the past six months has outpaced the S&P 500 by 16.7%, and its stock price has climbed to $407.86 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

UnitedHealth Group (NYSE:UNH) subsidiaries OptumRx and Emisar Pharma Services have reached a proposed settlement with the Federal Trade Commission over alleged anticompetitive insulin rebating practices. The FTC has paused further proceedings while it reviews the settlement terms related to insulin pricing and rebating conduct. The agreement focuses on resolving regulatory concerns tied to pharmacy benefit management activities in the insulin market. For investors watching UnitedHealth...

CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]

Berkshire Hathaway, now under CEO Greg Abel, disclosed in its Q1 2026 13F filing the acquisition of almost 40 million shares of Delta Air Lines (NYSE:DAL), a position valued at approximately $2.65 billion. The disclosure landed alongside full exits from Amazon (NASDAQ:AMZN), UnitedHealth (NYSE:UNH), and Domino’s Pizza (NASDAQ:DPZ), which makes the airline buy the loudest signal of a ... Berkshire Just Broke Warren Buffett’s Most Famous Rule and Poured $2.65 Billion Into This Airline

UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.

Warren Buffett’s Berkshire Hathaway (NYSE:BRK.B) fully exited its UnitedHealth Group (NYSE:UNH) position in Q1 2026, and David Tepper’s Appaloosa Management meaningfully reduced its UNH stake in the same quarter. Chase Coleman also sold UnitedHealth shares in Q1. Meanwhile, the sell-side stayed bullish, with a consensus target of $407.38 and 22 buy or strong buy ratings against a ... Both Berkshire Hathaway and David Tepper Silently Dumped the Same Healthcare Giant in the Same Quarter

UnitedHealth says AI is driving 2-to-1 returns and could cut operating costs by almost $1 billion this year.

With a short percentage of shares outstanding of 2.12%, UnitedHealth Group Incorporated (NYSE:UNH) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, subsidiaries of UnitedHealth Group Incorporated (NYSE:UNH), including OptumRx and Emisar Pharma Services, reached an agreement with the Federal Trade Commission to settle allegations that the companies engaged in anticompetitive and unfair rebating […]